For people already dealing with nausea and digestive sensitivity from GLP-1 medications, this can be a barrier to consistent use
Revolutionizing Metabolic Health with a Peptide Pairing (MOTS-c + Semaglutide) MOTS-c, a mitochondrial peptide, enhances cellular energy production and fat oxidation, supporting efficient metabolic function
The care team messaged me through the portal to ask follow-up questions about my intake
The SELECT trial, published in The Lancet (October 22, 2025), provides a landmark analysis confirming that the cardioprotective benefits of semaglutide extend beyond weight loss alone. The SELECT Trial: Study Overview The SELECT trial (NCT03574597) enrolled 17,604 participants aged 45 years and above across 41 countries and 804 sites
Becerra, the 24-year-old mentioned earlier, is passionate about optimizing men's hormones, as part of a bigger quest to boost testosterone, masculinity, and male self-confidence